The present invention be Application No. 201510066342.8, filing date on February 10th, 2015,
The divisional application of the patent of invention entitled " a kind of medicament treating corticosteroid femur head necrosis ".
Summary of the invention
It is an object of the invention to provide a kind of medicament treating corticosteroid femur head necrosis.
In order to realize the purpose of the present invention, the present invention provides one to treat corticosteroid femur head necrosis
Medicament, it is made up of the material of following weight portion: Flos Carthami 1-10 part, traumatic injury grass 10-20
Part, Pericarpium syzygii 10-20 part, Radix Angelicae Sinensis 5-15 part, Rhizoma valerianae latifoliae 1-10 part, Radix Campylotropis hirtellae 10-20
Part, Radix Cyathulae 5-15 part, Herba Lycopodii 10-20 part, Radix Salviae Miltiorrhizae 5-15 part, Rubus delavayi Franch. 10-20
Part, Radix Cudraniae 1-0 part, Rhizoma Drynariae 5-15 part, Herba Melasmatis arvensis 5-15 part, water Asia wood 10-20
Part, oil head grass 1-10 part, Radix Glycyrrhizae 1-10 part, lignum Ormosiae henryi 5-15 part, Herba Morindae Parvifoliae 10-20 part,
Herba Gynurae bicoloris 1-10 part, Parathelypteris glanduligera (Kunze) Ching 10-20 part, Radix Averrhoae Carambolae 10-20 part.
Preferably, the medicament for the treatment of corticosteroid femur head necrosis of the present invention is by following weight
Part material make: 8 parts of Flos Carthami, traumatic injury grass 12 parts, Pericarpium syzygii 15 parts, Radix Angelicae Sinensis 10 parts,
Rhizoma valerianae latifoliae 5 parts, Radix Campylotropis hirtellae 12 parts, Radix Cyathulae 10 parts, Herba Lycopodii 15 parts, Radix Salviae Miltiorrhizae 10 parts,
Rubus delavayi Franch. 12 parts, Radix Cudraniae 5 parts, Rhizoma Drynariae 10 parts, Herba Melasmatis arvensis 10 parts, water Asia wood 12
Part, oil head grass 5 parts, 8 parts of Radix Glycyrrhizae, lignum Ormosiae henryi 10 parts, Herba Morindae Parvifoliae 15 parts, Herba Gynurae bicoloris 10
Part, Parathelypteris glanduligera (Kunze) Ching 12 parts, Radix Averrhoae Carambolae 15 parts.
It is highly preferred that described medicament can be tablet, dispersible tablet, capsule, soft capsule or
Patch.
The present invention also provides for compositions in the medicine of preparation treatment corticosteroid femur head necrosis
Purposes, described compositions is made up of the material of following weight portion: Flos Carthami 1-10 part, traumatic injury grass
10-20 part, Pericarpium syzygii 10-20 part, Radix Angelicae Sinensis 5-15 part, Rhizoma valerianae latifoliae 1-10 part, Radix Campylotropis hirtellae
10-20 part, Radix Cyathulae 5-15 part, Herba Lycopodii 10-20 part, Radix Salviae Miltiorrhizae 5-15 part, Rubus delavayi Franch.
10-20 part, Radix Cudraniae 1-0 part, Rhizoma Drynariae 5-15 part, Herba Melasmatis arvensis 5-15 part, water Asia wood
10-20 part, oil head grass 1-10 part, Radix Glycyrrhizae 1-10 part, lignum Ormosiae henryi 5-15 part, Herba Morindae Parvifoliae 10-20
Part, Herba Gynurae bicoloris 1-10 part, Parathelypteris glanduligera (Kunze) Ching 10-20 part, Radix Averrhoae Carambolae 10-20 part.
Preferably, described compositions is made up of the material of following weight portion: 8 parts of Flos Carthami, traumatic injury
Grass 12 parts, Pericarpium syzygii 15 parts, Radix Angelicae Sinensis 10 parts, Rhizoma valerianae latifoliae 5 parts, Radix Campylotropis hirtellae 12 parts, river
Radix Achyranthis Bidentatae 10 parts, Herba Lycopodii 15 parts, Radix Salviae Miltiorrhizae 10 parts, Rubus delavayi Franch. 12 parts, Radix Cudraniae 5 parts,
Rhizoma Drynariae 10 parts, Herba Melasmatis arvensis 10 parts, water Asia wood 12 parts, oil head grass 5 parts, 8 parts of Radix Glycyrrhizae,
Lignum Ormosiae henryi 10 parts, Herba Morindae Parvifoliae 15 parts, Herba Gynurae bicoloris 10 parts, Parathelypteris glanduligera (Kunze) Ching 12 parts, Radix Averrhoae Carambolae 15
Part.
It is highly preferred that described medicine can be tablet, dispersible tablet, capsule, soft capsule or
Patch.
In the present compositions, Pericarpium syzygii, Radix Campylotropis hirtellae, traumatic injury grass are monarch drug;Flos Carthami,
Radix Angelicae Sinensis, Rhizoma valerianae latifoliae, Radix Cyathulae, Herba Lycopodii, Radix Salviae Miltiorrhizae, Rubus delavayi Franch. are ministerial drug;Radix Cudraniae, bone
Broken benefit, Herba Melasmatis arvensis, water Asia wood, oil head grass, lignum Ormosiae henryi, Herba Morindae Parvifoliae, Herba Gynurae bicoloris, Parathelypteris glanduligera (Kunze) Ching,
Radix Averrhoae Carambolae is adjuvant drug;Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, for making medicine.
Medicament synergism of the present invention, complement each other, play the merit of monarch altogether, with
Blood circulation promoting and blood stasis dispelling, subduing swelling and detoxicating are main, are aided with spleen reinforcing nourishing the liver, removing damp-heat, treat hormonal stock
Head necrosis effect is notable, clinic application and popularization.
The preparation of the medicament of the embodiment present invention
As a example by patch, the preparation technology of the medicament of the present invention is as follows:
(1) traumatic injury grass 120 grams, Pericarpium syzygii 150 grams, Herba Morindae Parvifoliae 150 grams, white hair are weighed
Serpentis 120 grams, lignum Ormosiae henryi 100 grams, add 6000 milliliters of water, equipped with in the flask of condensing tube
Being heated to reflux 4 hours, filter after being cooled to room temperature, adding ethanol in filtrate to alcohol content is
80 volume %, ambient temperatare filters after putting 24 hours, is evaporated after being reclaimed by the ethanol in filtrate
Aqueous solution obtains dry cream 1;
(2) Herba Lycopodii 150 grams, Radix Cudraniae 50 grams, Radix Averrhoae Carambolae 150 grams, Radix Campylotropis hirtellae are weighed
120 grams, adding 6000 milliliters of water, heating was filtered, in filtrate after 1 hour under reflux
Add 2mol/L aqueous hydrochloric acid solution regulation pH value to 6.0, be subsequently added Herba Melasmatis arvensis 100 grams,
Oil head grass 50 grams, Herba Gynurae bicoloris 100 grams, Radix Cyathulae 100 grams, be heated at reflux mistake after 4 hours
Filter, filtrate is evaporated and obtains dry cream 2;
(3) weigh 80 grams of Flos Carthami, Radix Angelicae Sinensis 100 grams, Rhizoma valerianae latifoliae 50 grams, 80 grams of Radix Glycyrrhizae,
Radix Salviae Miltiorrhizae 100 grams, Rhizoma Drynariae 100 grams, Rubus delavayi Franch. 120 grams, 120 grams of water Asia wood, add
The ethanol water of 5000 milliliter of 85 volume %, is heated at reflux 4 hours, after being cooled to room temperature
Filter, be evaporated aqueous solution after being reclaimed by the ethanol in filtrate and obtain dry cream 3;
(4) merge above-mentioned dry cream 1, dry cream 2 and dry cream 3, after pulverizing, add vaseline 400
Gram and lanoline 200 grams, be applied in after stirring on 500 blocks of non-woven fabrics.Every piece of non-woven fabrics length and
Wide being 20 centimetres, thickness is 1 centimetre.
The curative effect of the medicament of the experimental example present invention
1 data and method
1.1 physical data
This group corticosteroid femur head necrosis patient totally 60 example, all meets " new Chinese medicine treatment stock
The guideline of clinical investigations of bone bland necrosis " in about femur head necrosis diagnosis and treatment advise
Model, gets rid of and has clear and definite hip trauma history person and congenital hip developmental disorder person.Staging scale
With reference to luxuriant and rich with fragrance card (Ficat) aging schedule.
60 example patients are divided into treatment group 30 example and matched group 30 example.Wherein treatment group male
18 examples, women 12 example;Patient age between 24-51 year, 37.7 years old mean age;Suffer from
Sick position list hip 20 example, double hip 10 examples;I phase 5 hip, II phase 18 hip, III phase 11 hip,
IV phase 6 hip.Matched group male 20 example, women 10 example;Patient age between 21-53 year,
38.2 years old mean age;Disease sites list hip 22 example, double hip 8 hips;I phase 4 hip, the II phase
16 hips, III phase 12 hip, IV phase 6 hip.Two groups of patients are in the equal nothing of difference of above-mentioned each side
Statistical significance (p > 0.05), has comparability.
1.2 observation index
1.2.1 femur head necrosis clinical symptoms, sign scoring
Before treatment and after treatment, with reference to table 1, femur head necrosis clinical symptoms, sign situation are entered
Row scoring.
Table 1 femur head necrosis clinical symptoms, sign scalar quantization table
1.2.2 x-ray inspection
Utilize x-ray inspection that articular surface form, joint space and bone structure are observed.This
Item checks and is operated by specialist.
1.3 Therapeutic Method
Treatment group uses the patch of the present invention of preparation in embodiment to treat, by 1 piece of patch
It is attached to suffer from hip, if single hip then uses 1 piece of patch, if double hip then uses 2 pieces of patches
Agent, often hip 1 piece of patch of use is suffered from place, and 2 times/day, 30 days be a course for the treatment of.Matched group takes
With XIANLING GUBAO JIAONANG (Guizhou Tongjitang Pharmaceutical Co., Ltd), 3 tablets/time, 2 times/day, 30
It is a course for the treatment of.
1.4 criterion of therapeutical effect
1.4.1 evaluation of clinical curative effect standard
With reference to " guideline of clinical investigations of new Chinese medicine treatment aseptic necrosis of femoral head " system
Fixed.Therapeutic index (N) and effective percentage is calculated according to score value of marking for twice before treatment and after treatment.
Recovery from illness: clinical symptoms, sign disappear or substantially disappear, N >=95%;
Effective: clinical symptoms, sign are obviously improved, N=70%-95%;
Effective: clinical symptoms, sign all take a favorable turn, N=30%-70%;
Invalid: clinical symptoms, sign are not improved or increase the weight of N < 30%.
Wherein,
Score value × 100% before therapeutic index (N)=(score value after score value-treatment before treatment)/treatment
Effective percentage=(recovery from illness+effective+effectively) number of cases/total number of cases × 100%
1.4.2 x-ray checks the standard of curative effect evaluation
This inspection is operated by specialist.The standard of curative effect evaluation is worked out as follows:
Recovery from illness: x-ray shows that recovery is normal;
Effective: x-ray is shown with and is clearly better, substantially close to normally;
Effective: x-ray is shown with improvement;
Invalid: x-ray shows unchanged.
1.5 statistical method
SPSS17.0 statistical software is used to carry out data analysis.Measurement data withRepresent,
Use t inspection;Enumeration data uses x2Inspection.Statistically significant with p≤0.05 for difference.
2 results
2.1 clinical symptoms, sign are marked
What before and after two groups of patient treatments, clinical symptoms, sign scoring score value changed is relatively shown in Table 2,
Curative effect is shown in Table 3.
The comparison of table 2 clinical symptoms, sign scoring score value change
Note: compare with before treatment, * p < 0.05;Compare with matched group, * * p < 0.05
As can be seen from Table 2, two groups of patients score value not statistically significant (p > before the treatment
0.05), and after treating 30 days, the score value of two groups has declined, and difference has statistics
Meaning (p < 0.05), and treatment group relatively matched group decline become apparent from, group difference has statistics
Learn meaning (p < 0.05).
Table 3 Clinical efficacy comparison
Note: compare with matched group, * p < 0.05
Table 3 shows, the difference of two groups of patient clinical curative effects is statistically significant (p < 0.05).
This shows that treatment group symptom takes a turn for the better and is better than matched group, and the clinical efficacy of the medicament of the present invention is better than celestial being
Spirit bone preserves capsule.
2.2 x-ray signs
Before and after two groups of patient treatments, the change of x-ray sign is relatively shown in Table 4.
Table 4 x-ray sign changes
Note: compare with matched group, * p < 0.05
As can be seen from Table 4, the difference in terms of two groups of patient's x-ray signs is statistically significant
(p < 0.05), shows that the curative effect of the medicament of the present invention is better than XIANLING GUBAO JIAONANG.